| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775206A1 Dual hybrid system |
| 05/28/1997 | EP0775204A1 Antitumor antisense oligonucleotides |
| 05/28/1997 | EP0775160A1 Cyclic hexapeptide somatostatin analogues |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0775156A1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives |
| 05/28/1997 | EP0775150A1 Endotoxin reduction or removal process |
| 05/28/1997 | EP0775142A1 Substituted o6 -benzylguanines and 6(4)-benzyloxypyrimidines |
| 05/28/1997 | EP0775103A1 Retinoic acid x-receptor ligands |
| 05/28/1997 | EP0774973A1 Treatment of cancer with human chorionic gonadotropin |
| 05/28/1997 | EP0774963A1 Pharmaceutically stable oxaliplatinum preparation |
| 05/28/1997 | EP0710107A4 N,n,n-trimethylsphingosine derivatives |
| 05/28/1997 | EP0579614B1 Imidazoacridines and their antineoplastic use |
| 05/28/1997 | EP0569380B1 Acridine derivatives |
| 05/28/1997 | EP0546092B1 Therapeutic ribozyme compositions |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150803A Pyrazolo and pyrrolopyridines |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/28/1997 | CN1150548A Drug for curing leukopenia and radiation damage |
| 05/27/1997 | US5633393 Estradiol derivative-alkylating agent conjugate with reduced hormonal activity, process for preparing the same, compounds useful for the preparation thereof, and growth inhibiting compositon containing the conjugate or estradiol derivative. |
| 05/27/1997 | US5633351 Targeting protein-diagnostic/therapeutic agent conjugates having Schiff base linkages |
| 05/27/1997 | US5633280 Urethanes and ureas that induce cytokine production |
| 05/27/1997 | US5633279 5-substituted derivatives of mycophenolic acid |
| 05/27/1997 | US5633261 Immunostimulating swainsonine analogs |
| 05/27/1997 | US5633241 Administering as antileukemia agent |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/27/1997 | US5633016 Administering cisplatin and topotecan synergistic mixture as antitumor agents |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | US5632970 Fluoresence detection using texaphyrins |
| 05/22/1997 | WO1997018312A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | WO1997018309A1 E6 binding proteins |
| 05/22/1997 | WO1997018241A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | WO1997018231A1 Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 05/22/1997 | WO1997018215A1 Analogues of n-acetylardeemin, method of preparation and uses thereof |
| 05/22/1997 | WO1997018212A1 Aryl and heteroaryl purine compounds |
| 05/22/1997 | WO1997018192A1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 05/22/1997 | WO1997018188A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 05/22/1997 | WO1997017993A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 05/22/1997 | CA2237783A1 E6 binding proteins |
| 05/22/1997 | CA2237528A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | CA2235695A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/21/1997 | EP0774459A1 Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing them |
| 05/21/1997 | EP0774458A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774457A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774258A1 Composition containing 5-fluorouracil and d4T for use in the treatment of retroviral infection |
| 05/21/1997 | EP0774255A1 Use of ursolic acid for the manufacture of a medicament for suppressing metastasis |
| 05/21/1997 | EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy |
| 05/21/1997 | EP0773996A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 05/21/1997 | EP0773994A1 Receptor-ligand assay |
| 05/21/1997 | EP0773958A1 PTH OR PTHrP ANTAGONISTS |
| 05/21/1997 | EP0773951A1 Dinucleoside-5',5'-pyrophosphates |
| 05/21/1997 | EP0773950A1 Linked peptide nucleic acids |
| 05/21/1997 | EP0773949A1 D-mannose or xylitol esters and their use as drugs |
| 05/21/1997 | EP0773943A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 05/21/1997 | EP0773938A1 Semi-synthetic taxanes with anti-tumoural activity |
| 05/21/1997 | EP0773787A1 HLA binding peptides and their uses |
| 05/21/1997 | EP0773785A2 Treatment of cancer using hsv mutant |
| 05/21/1997 | EP0773782A1 Terpenoidic derivatives (sarcodictyins) useful as antitumor agents |
| 05/21/1997 | CN1150428A Corticotropin releasing factor antagonists |
| 05/21/1997 | CN1150423A New taxoids, preparation thereof and pharmaceutical compositions containing them |
| 05/21/1997 | CN1150422A Taxoids, preparation and pharmaceutical compositions containing them |
| 05/21/1997 | CN1150419A Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/21/1997 | CN1150388A Immunotherapeutic agent and its use |
| 05/21/1997 | CN1150155A Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 05/21/1997 | CN1034938C Process for preparing 4H-naphtho [1,2-b] pyran compound |
| 05/21/1997 | CN1034930C Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives and use thereof |
| 05/21/1997 | CN1034929C Ornithine decarboxylase inhibiting cyclic aminooxy compounds and use thereof |
| 05/21/1997 | CA2190693A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/21/1997 | CA2190692A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/20/1997 | US5631394 Pharmaceutically active ceramide-related compounds |
| 05/20/1997 | US5631376 Retroviral protease inhibiting compounds |
| 05/20/1997 | US5631348 Protein sequence of the plant toxin gelonin |
| 05/20/1997 | US5631293 Cardiovascular disorders |
| 05/20/1997 | US5631280 Inhibitors of farnesyl-protein transferase |
| 05/20/1997 | US5631263 Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
| 05/20/1997 | US5631247 Antilipemic agents, cardiovascular disorders, urogenital disorders and osteoporosis |
| 05/20/1997 | US5631238 Anticarcinogenic agents |
| 05/20/1997 | US5631236 Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| 05/20/1997 | US5631219 Method of stimulating hematopoiesis with hemoglobin |
| 05/16/1997 | CA2189097A1 Composition and method of treating retroviral infection |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017433A1 Tissue-specific and target rna-specific ribozymes |
| 05/15/1997 | WO1997017332A1 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation |
| 05/15/1997 | WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 05/15/1997 | WO1997017079A1 Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease |
| 05/15/1997 | WO1997017070A1 Inhibitors of protein isoprenyl transferases |
| 05/15/1997 | WO1997017069A1 Methods for treating resistant tumors |
| 05/15/1997 | WO1997013781A3 Synthetic peptides that inhibit il-6 activity |
| 05/15/1997 | WO1997003635A3 P16 expression constructs and their application in cancer therapy |
| 05/15/1997 | CA2237200A1 Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease |
| 05/15/1997 | CA2236543A1 Methods for treating resistant tumors |
| 05/15/1997 | CA2190220A1 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic aid, and medicament containing them |
| 05/14/1997 | EP0773441A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 05/14/1997 | EP0773293A2 Genetically engineered tumour cell lines and their use in the screening of antitumour-compositions |
| 05/14/1997 | EP0773221A1 Stable crystalline tetrahydrofolic acid salts |
| 05/14/1997 | EP0773217A1 Benzothiphene derivatives for treating resistant tumors |
| 05/14/1997 | EP0773026A2 NK-1 receptor antagonists for the treatment of cancer |
| 05/14/1997 | EP0772689A2 Retroviral vectors having a reduced recombination rate |